ELIOS Announces New Research Results Visit our Press Room →

For Patients

For Patients

There remains a need to create a host active specific immune response, generating an army of tumor-reactive T-cells that can attach a patient’s disease alone and improve the outcomes for the patients on therapies that manipulate T cells in the adjuvant and metastatic settings.

Menu